Clinical Trial Update: Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing universal aspirin to screening-indicated aspirin for the prevention of preeclampsia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Women and Infants Hospital of Rhode Island | Conditions: Medication Adherence, Preeclampsia | Phase 4 | Status: WITHDRAWN